Check out your Company Bowl for anonymous work chats.
You’ve finished your cancer treatment and shown no evidence of disease — for weeks, months or maybe even years. Then, a routine scan or bloodwork reveals something concerning. Your doctor thinks the cancer might have returned. So, what do you do now?
Only Possible Here. The Campaign to End Cancer, celebrates and fuels the groundbreaking innovations and transformative advancements that define MD Anderson.
MD Anderson teams and Texas Children’s work together on the first-of-its-kind joint venture to begin unified clinical operations as Kinder Children’s Cancer Center
Nobody does cancer treatment quite like MD Anderson.
MD Anderson’s Boot Walk to End Cancer® is Saturday, Nov. 15, but there’s still time to register and prepare for event day.
Current Corporate Alliances
MD Anderson and Phoenix SENOLYTIX announce strategic cross-licensing agreement to enhance inducible switch technologies for cell and gene therapies
The James P. Allison Institute™ at The University of Texas MD Anderson Cancer Center hosted its third annual scientific symposium, “The Multiverse of Mechanistic Processes Impacting Immunity,” on Oct. 24 at the TMC3 Collaborative Building in the Texas Medical Center’s Helix Park.
MD Anderson’s top nurses receive The Brown Foundation Award for Excellence in Oncology Nursing
As part of our mission to eliminate cancer, MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers. Look through our database to find studies for which you may be eligible.
